 |
|
|
|
|
|
|
| Article 1 to 10 out of 32
|
|
-
Fluxion Biosciences Signs New Distributor for Benelux and Scandinavia
(04 Dec 2008)
Westburg BV to Distribute BioFlux Line of Live Cell Imaging Products
Fluxion Biosciences announced an exclusive distribution agreement with The Netherlands-based Westburg BV. Westburg BV will handle sales and service of Fluxion's BioFlux research tools for live cell image analysis in Belgium, The Netherlands, ......
-
Philips and Concateno Announce Revolutionary Drugs-of-Abuse Testing System
(26 Nov 2008)
Concateno plc, provider of drug and alcohol testing programmes, and Royal Philips Electronics have announced an innovative handheld drugs-of-abuse detection device. Concateno-Philips pioneering system will make testing for drugs such as ......
-
BioFocus DPI and ZoBio announce marketing agreement
(17 Nov 2008)
BioFocus DPI and ZoBio announced that they have signed a worldwide marketing and sales agreement for ZoBio’s fragment-based NMR technologies. Under the terms of the agreement BioFocus DPI will sell ZoBio’s services either as a stand-alone ......
-
InteRNA Technologies and VU University Medical Center to Develop microRNA-based Diagnostics and Therapeutics for Cancer
(03 Nov 2008)
InteRNA Technologies B.V. and VU university medical center in Amsterdam, VUmc, announced the signing of a framework research agreement to develop microRNA (miRNA)-based diagnostics and therapeutics for cancer using InteRNA’s proprietary library ......
-
PCA3 Test May Help Distinguish Aggressive Prostate Cancer
(31 Oct 2008)
The PCA3 Test May Help Distinguish Between Benign and Aggressive
The number of prostate cancer cases is increasing rapidly. Fortunately not all these tumours need to be operated - some are slow growing or indolent. The question remains: how do we reliably establish which tumour is aggressive and which is ......
-
Cooperation Makes Microreactor Technology Accessible to Fine-Chemistry and Pharmacy
(13 Oct 2008)
The Dutch companies Micronit Microfluidics, FutureChemistry and Flowid announced the start of a cooperation named Access2Flow. Together, the three companies will offer a new generation of microreactor systems that enable chemists to quickly and ......
-
Nobel Prize to HPV Researcher Highlights Importance of Cervical Cancer Screening and Prevention
(08 Oct 2008)
QIAGEN's HPV testing technologies are a successful commercialization of the Nobel Prize in Medicine winner's research
The Nobel Prize-winning discovery of the causal link between human papillomavirus (HPV) and cervical cancer has spurred lifesaving prevention technologies -- such as HPV testing and HPV vaccines -- that are helping to eradicate cervical cancer ......
-
Women in Europe for a Common Future: REACH SIN* list 1.0: hazardous chemicals to be substituted now!
(19 Sep 2008)
NGO‘s take over work that should be done by the authorities
In June 2007, the new EU policy on chemicals, REACH, entered into force. Over the next decade thousands of chemicals manufactured or imported into the EU will have to be registered with the newly established European Chemicals Agency, ECHA. One ......
-
EtOH-REACH Launches Joint Registration Initiative for European Ethanol Industry
(28 Aug 2008)
Taking effect on 1 June 2007, REACH (Registration, Evaluation and Authorisation of Chemicals) is the European chemicals legislation which applies to all 27 EU countries plus Norway, Iceland and Liechtenstein. According to Regulation (EC) No ......
-
Phenomenex Expands International Network With New Office in the Netherlands
(18 Jul 2008)
Phenomenex Inc announced the grand opening of its new subsidiary in Utrecht, the Netherlands. The new entity, Phenomenex B.V., will enable the company to serve the growing research and development communities in the Benelux region with direct ......
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon